Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30737462.
- Also identified by DOI 10.1038/s41583-019-0132-6 and PMC identifier 9382875.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alzheimer disease (AD) is a major cause of age-related dementia. We do not fully understand AD aetiology and pathogenesis, but oxidative damage is a key component. The brain mostly uses glucose for energy, but in AD and amnestic mild cognitive impairment glucose metabolism is dramatically decreased, probably owing, at least in part, to oxidative damage to enzymes involved in glycolysis, the tricarboxylic acid cycle and ATP biosynthesis. Consequently, ATP-requiring processes for cognitive function are impaired, and synaptic dysfunction and neuronal death result, with ensuing thinning of key brain areas. We summarize current research on the interplay and sequence of these processes and suggest potential pharmacological interventions to retard AD progression.
Medical subject headings
- Alzheimer Disease
- Brain
- Glucose Intolerance
- Glycolysis
- Oxidative Stress